arrow
L

Lisa H. Tostanoski

Beth Israel Deaconess Medical Center
H指数:33
被引数:8,047

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues

同种异体间充质干细胞(allogeneic mesenchymal stem cells)的mRNA工程化改造,能够协同递送T细胞结合器(T cell engagers)和免疫治疗信号(immunotherapeutic cues)。

2025-11-280
PRE
Mining the CD4 antigen repertoire for next-generation tuberculosis vaccines

挖掘CD4抗原谱以开发下一代结核病疫苗

Cell
IF42.5
2025-09-150
OAAI
On-patient medical record and mRNA therapeutics using intradermal microneedles

患者身上的医疗记录和利用真皮内微针的mRNA疗法

2025-02-242
OA
Zeolitic imidazolate frameworks activate endosomal Toll-like receptors and potentiate immunogenicity of SARS-CoV-2 spike protein trimer

沸石咪唑酯框架激活内体Toll样受体并增强SARS-CoV-2刺突蛋白三聚体的免疫原性

2024-03-083
OAAI
A microneedle vaccine printer for thermostable COVID-19 mRNA vaccines

用于热稳定新型冠状病毒肺炎mRNA疫苗的微针疫苗打印机

2023-04-2459
OA
Reduced pathogenicity of the SARS-CoV-2 omicron variant in hamsters
MED
IF11.8
2022-04-01134
OAAI
SARS-CoV-2 receptor binding domain displayed on HBsAg virus-like particles elicits protective immunity in macaques

HBsAg病毒样颗粒上显示的SARS-CoV-2受体结合域在猕猴中引起保护性免疫

2022-03-1822
OAAI
Passive transfer of Ad26.COV2.S-elicited IgG from humans attenuates SARS-CoV-2 disease in hamsters
2022-01-104
OAAI
Protective Efficacy of Rhesus Adenovirus COVID-19 Vaccines against Mouse-Adapted SARS-CoV-2

恒河猴腺病毒新型冠状病毒肺炎疫苗对小鼠适应性SARS-CoV-2的保护作用

2021-11-0915
OAAI
Immunity elicited by natural infection or Ad26.COV2.S vaccination protects hamsters against SARS-CoV-2 variants of concern
2021-11-0330
OAAI
Prior infection with SARS-CoV-2 WA1/2020 partially protects rhesus macaques against reinfection with B.1.1.7 and B.1.351 variants
2021-11-0316
OAAI
Engineered SARS-CoV-2 receptor binding domain improves manufacturability in yeast and immunogenicity in mice
2021-09-0764
OAAI
Immunogenicity of COVID-19 mRNA Vaccines in Pregnant and Lactating Women
2021-06-15301
OA
Immunogenicity of the Ad26.COV2.S Vaccine for COVID-19
2021-04-20229
OA